CSM Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.8M Sell
219,688
-3,097
-1% -$722K 1.19% 13
2026
Q1
$54.5M Sell
222,785
-33,255
-13% -$7.75M 1.34% 10
2025
Q4
$53M Buy
256,040
+9,333
+4% +$1.85M 1.44% 10
2025
Q3
$45.7M Buy
246,707
+119,882
+95% +$20.5M 1.28% 9
2025
Q2
$19.4M Buy
+126,825
New +$19.5M 0.57% 52
2024
Q1
Sell
-1,297
Closed -$203K 141
2023
Q4
$203K Hold
1,297
0.01% 141
2023
Q3
$202K Sell
1,297
-200
-13% -$33K 0.02% 135
2023
Q2
$248K Sell
1,497
-600
-29% -$96.8K 0.02% 141
2023
Q1
$325K Hold
2,097
0.03% 131
2022
Q4
$370K Hold
2,097
0.04% 123
2022
Q3
$343K Hold
2,097
0.04% 121
2022
Q2
$372K Hold
2,097
0.03% 113
2022
Q1
$372K Hold
2,097
0.03% 120
2021
Q4
$359K Sell
2,097
-1,000
-32% -$164K 0.02% 146
2021
Q3
$500K Hold
3,097
0.04% 128
2021
Q2
$510K Buy
+3,097
New +$513K 0.03% 133

Other funds holding JNJ

CSM Advisors's JNJ Position: Q2 2026 in Review

CSM Advisors reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, selling an estimated $722K and leaving 219,688 shares worth $55.8M. The position accounts for 1.19% of the portfolio, ranked #13.

CSM Advisors first reported a position in JNJ in Q2 2021 and has held it in 16 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • CSM Advisors held 219,688 shares of Johnson & Johnson worth $55.8M as of Q2 2026.
  • CSM Advisors sold 3,097 Johnson & Johnson shares in Q2 2026, an estimated $722K.
  • Johnson & Johnson made up 1.19% of CSM Advisors's portfolio in Q2 2026, its #13 holding.
  • CSM Advisors first reported a position in Johnson & Johnson in Q2 2021 and has held it in 16 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.